Z
ZURA BIO LIMITED CLASS A ORDINARY SHARES
NASDAQ: ZURA (Zura Bio Limited)
Last update: 12 hours ago5.23
-0.06 (-1.13%)
| Previous Close | 5.29 |
| Open | 5.40 |
| Volume | 366,205 |
| Avg. Volume (3M) | 1,069,924 |
| Market Cap | 496,226,112 |
| Price / Book | 2.29 |
| 52 Weeks Range | |
| Earnings Date | 13 Aug 2026 |
| Diluted EPS (TTM) | -0.770 |
| Current Ratio (MRQ) | 8.14 |
| Operating Cash Flow (TTM) | -34.16 M |
| Levered Free Cash Flow (TTM) | -17.40 M |
| Return on Assets (TTM) | -31.40% |
| Return on Equity (TTM) | -55.05% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Zura Bio Limited | Mixed | Bullish |
AIStockmoo Score
1.5
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 4.0 |
| Average | 1.50 |
|
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 29.16% |
| % Held by Institutions | 70.62% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |